What information is required when a Schedule III controlled substance prescription is transcribed by an authorized agent?

When a Schedule III controlled substance prescription is transcribed by an authorized agent, it is essential that both the name and address of the practitioner and the name and address of the agent are included. This requirement ensures that there is clear identification of not only the prescriber but also the individual responsible for transcribing the prescription, thus maintaining accountability within the prescribing process.

The presence of this information protects patient safety and helps prevent misuse or errors in medication dispensing. It establishes a clear chain of communication regarding who authorized the prescription and who transcribed it, which is crucial in situations where the authenticity of a prescription may be questioned.

In contrast, merely including the name and address of the practitioner without the agent's details would not provide a complete picture of the prescription's origination and could lead to complications should any discrepancies arise. Additionally, having only the name of the agent or any combination of these factors without the full context would not meet regulatory compliance and could pose risks to the integrity of the prescribing process. This comprehensive identification is a necessary safeguard within the regulatory framework governing controlled substances.